Login

Gianmarco Orgnoni, COO of Vection Technologies (ASX: VR1), joins ASX Investor Channel to discuss company developments and strategies. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Impact of Technology and Pro Bono on the Future of Law Practice
00:10:00
Forget Budgeting: Try the Simple Spend Method! | Bjorn Amundson - PARTNER, FINANCIAL PLANNER of Quarry Hill Advisors
00:10:00
Exploring Retirement Plan Options: Simple IRAs and Roth Conversions | Adam Taylor, CEO, Taylor Financial.
00:10:00
Advancing Education by 2030: The Impact of Performance Data on Student Achievement
00:10:00
A company introduction movie for SAMICK THK CO., LTD., part of the Korean SAMICK THK Group.
00:10:00
Silver Lake's Revised Proposal for St. Barbara Sparks Shareholder Interest Amid Hostile Deal
00:10:00
We talk to Vince Hawksworth, CEO of Mercury, about the challenges of becoming CEO and his support for the Multiple Sclerosis Society of New Zealand.
00:10:00
Hafnia CEO Mikael Skov on Product Tankers, Oil Demand, and Investing | Mikael Skov - CEO of Hafnia Ltd
00:10:00
Henderson Land Honored in Singapore with Second 'Developer of the Year' Award|Mr Yu Ching Yan Johnny,Advisor to Chairman,Henderson Land Development Co. Ltd.
00:10:00
O3 Mining Unveils Marvin Project: Robust Value and Expansion Potential
00:10:00
Nucor Gold: Advancing Exploration with 90,000 Meters Drilled in Ghana
00:10:00
BMEX Gold: Quebec Gold Projects Exploration Update

© 2017 - Neuhu+